News from sirtex medical limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 03, 2017, 03:30 ET New Analysis Reveals First-Line Treatment Data on SIR-Spheres® Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer

BARCELONA, Spain, July 3, 2017 /CNW/ - SIRFLOX and FOXFIRE Global findings suggest that adding liver-directed Selective Internal Radiation Therapy (SIRT) to standard first-line chemotherapy may...


Jun 05, 2017, 10:15 ET SIR-Spheres® Y-90 Resin Microspheres Showed No Significant Difference in Overall Survival (OS) Compared to Sorafenib in Advanced HCC with Significantly Fewer Severe Adverse Events, New Asia-Pacific

Final Results of SIRveNIB Study presented at 2017 American Society of Clinical Oncology Meeting CHICAGO, June 5, 2017 /CNW/ - For the second time in less than two months, a major head-to-head study...


May 24, 2017, 03:35 ET Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows

MAINZ, Germany, May 24, 2017 /CNW/ - Surgeons' blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases treated in the...


Jun 06, 2016, 08:45 ET SIRveNIB, a Major Primary Liver Cancer Study in the Asia-Pacific Region, Completes Enrolment

Results of Asia-Pacific Hepatocellular Carcinoma Trials Group (AHCC) Randomised Controlled Study Comparing Sorafenib and SIR-Spheres® Y-90 resin microspheres in the Treatment of Unresectable...


Feb 23, 2016, 03:00 ET SIRFLOX Study Published in Journal of Clinical Oncology

Prestigious ASCO Journal Publishes 530-patient SIRFLOX Study on SIR-Spheres® Y-90 resin microspheres in the Management of Metastatic Colorectal Cancer (mCRC) SYDNEY, Feb. 23, 2016 /CNW/ - Sirtex...


Jan 19, 2016, 15:54 ET Treatment Results of SIR-Spheres® Y-90 Resin Microspheres are Similar Regardless of Patient Age, New Publication Shows

606-patient MORE Study Sub-Group Analysis Examined Outcomes for Elderly (≥70 years) and Very Elderly (≥75 years) Patients with Liver-Dominant Metastatic Colorectal Cancer (mCRC) SYDNEY, Jan. 19, 2016 ...


Jul 04, 2015, 05:30 ET New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer

Adding SIR-Spheres® Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends Progression-Free Survival in...


May 30, 2015, 17:00 ET SIRFLOX Study Presented at ASCO 2015 Annual Meeting

CHICAGO, May 30, 2015 /CNW/ - Clinical investigators cite significance of 7.9 month improvement in Progression-Free Survival in the liver for patients with unresectable metastatic colorectal cancer...


Mar 17, 2015, 08:00 ET Sirtex Reports Preliminary SIRFLOX Study Results

SYDNEY, March 17, 2015 /CNW/ - In the first-line treatment of non-resectable metastatic colorectal cancer: SIRFLOX study does not show a statistically significant improvement in overall...


Jan 29, 2015, 11:22 ET FOXFIRE and FOXFIRE Global Studies Complete Patient Enrolment

SYDNEY, Jan. 29, 2015 /CNW/ - Combined data from more than 1,000 patients being collected to assess overall survival (OS) benefit of adding first-line SIR-Spheres® Y-90 resin microspheres treatment...


Jul 24, 2013, 13:25 ET Innovative Cancer Treatment Supported by NICE

NEW UK GUIDANCE SHOULD IMPROVE PATIENT ACCESS TO SIR-SPHERES® MICROSPHERES FOR PRIMARY LIVER CANCER LONDON, July 24, 2013 /CNW/ - The UK National Institute for Health and Clinical Excellence (NICE)...


Dec 11, 2012, 03:00 ET Sirtex Medical Limited Launches New Global Website for SIR-Spheres® Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours

SYDNEY, Dec. 11, 2012 /CNW/ - http://www.sirtex.com informs doctors, patients and investors about the world's most widely used and widely studied form of SIRT for all cancers in the liver Sirtex...


Feb 03, 2012, 02:00 ET New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients

PARIS, Feb. 3, 2012 /CNW/ - 'SARAH' - a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular...